Clinical Trial

Assessing Changes in Myocardial Tissue and Blood in Patients With Advanced Heart Disease

Recruiting
View on ClinicalTrials.gov →
Summary
Hypothesis: Tissue and serum samples collected from end-stage heart failure patients receiving left ventricular assist device implantation (LVAD) or heart transplantation will provide information regarding the basic science of heart disease. Tissue and serum samples collected from a limited numbers of "healthy controls" (donor grafts that were not utilized for heart transplantation) will serve as a comparator in research database projects. Design: This is a registry project; there are no investigational treatments, drug or procedures associated with participation in registry activities. This project is an organized functional data and tissue data gathering and storing (database) endeavor with specific focus on the functional, structural, and molecular aspects of heart failure. Data collection will not immediately influence the course of treatment for any patient.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2028-01 -> 2030-01 2026-08-14
minor Completion pushed: 2028-01 -> 2030-01 2026-08-14
Trial Details
NCT Number NCT01099982
Lead Sponsor University of Utah
Collaborators: Intermountain Health Care, Inc., VA Salt Lake City Health Care System, Hunter Holmes McGuire VA Medical Center
Conditions Congestive Heart Failure
Enrollment 300 participants
Start Date 2008-09
Primary Completion 2030-01 (estimated)
Study Completion 2030-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-13